Good news: Mild COVID-19 induces lasting antibody protection
Watch the video by the Incubig team to know what research studies are saying about developing long lasting immunity against covid19 infection.
People who have had mild illness develop antibody-producing cells that can last lifetime, according to a study from researchers at Washington University School of Medicine in St. Louis.
The key to figuring out whether COVID-19 leads to long-lasting antibody protection, Ellebedy realized, lies in the bone marrow. Watch the video to know more.
Check out some of the sources.
Good news: Mild COVID-19 induces lasting antibody protection
https://www.nature.com/articles/s41586-021-03647-4
Don’t forget to subscribe to our channel.
https://www.youtube.com/channel/UCfNtQYfy-p55Nyy6gTBH4Pw?sub_confirmation=1
Thank you.
Keep Innovating.
Follow us on: Insta: https://www.instagram.com/incubig
LinkedIn: https://www.linkedin.com/company/incubig
Facebook: https://www.facebook.com/incubig
Twitter: https://twitter.com/IncubigAI
#Incubig #covid19 #longlastingimmunity#coronacontrol #coronavirus #Sarscov2 #sars#biology #cellularbiology #immunity #antibodies #bonemarrow #spikeprotien #memorycells #bloodcells #whitebloodcells #wbcs#wuhan #wuhanlab #wuhaninstituteofvirology #China #gatesfoundation #billgates #melindagates #anthonyfauci #NIH #niaid #patents#Covid19cure #drugs #contagion #vaccination #mRNA #Moderna#IncubigInsights #InnovationInsights #ResearchInsights
